About us Contact Terms of Use Data Sources Publications FAQ
SLC16A14 logo

SLC16A14

Monocarboxylate transporter 14

Expression

StudyTumor samplesMaxQ3Q2Q1MinNormal samplesMaxQ3Q2Q1MinLog2 (T vs N)
Adrenocortical (ACC) 77 1.91 1.64 1.49 1.32 0.24 126 1.83 1.48 1.36 1.24 -0.09 0.12
Bladder (BLCA) 406 2.03 1.19 1.04 0.84 0.27 9 1.12 1.12 1.02 0.93 0.86 0.02
Breast (BRCA) 1067 2.39 1.53 1.38 1.19 0.21 178 1.65 1.40 1.28 1.16 0.80 0.10
Cervical (CESC) 297 2.57 1.42 1.19 0.99 0.30 10 1.56 1.51 1.27 1.23 1.17 -0.08
Cholangiocarcinoma (CHOL) 36 1.94 1.25 0.97 0.84 0.31 0
Colon (COAD) 443 1.77 1.25 1.08 0.83 0.21 166 1.41 1.05 0.91 0.80 -0.09 0.17
B-cell lymphoma (DLBC) 42 1.50 0.91 0.65 0.49 0.12 337 1.47 0.63 0.38 0.01 -0.01 0.26
Esophageal (ESCA) 142 1.98 1.41 1.21 0.93 0.30 271 1.66 1.38 1.32 1.24 -0.09 -0.10
Glioblastoma (GBM) 160 1.77 1.47 1.31 1.16 0.57 214 2.00 1.73 1.65 1.60 -0.09 -0.34
Head and neck (HNSC) 432 1.95 1.31 1.06 0.84 -0.08 55 2.30 1.49 1.38 1.22 0.88 -0.32